T 1581/12 (Outer membrane protein immunogen Neisseria/GLAXOSMITHKLINE) of 15.09.2016
- European Case Law Identifier
- ECLI:EP:BA:2016:T158112.20160915
- Date of decision
- 15 September 2016
- Case number
- T 1581/12
- Petition for review of
- -
- Application number
- 05077865.3
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Neisseria antigens and compositions
- Applicant name
- GlaxoSmithKline Biologicals S.A.
- Opponent name
- Wyeth et al.
- Board
- 3.3.08
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 114(2)European Patent Convention Art 123(2)European Patent Convention Art 52European Patent Convention Art 54European Patent Convention Art 56European Patent Convention Art 57European Patent Convention Art 76(1)European Patent Convention Art 83Rules of procedure of the Boards of Appeal Art 12(4)Rules of procedure of the Boards of Appeal Art 13(1)Rules of procedure of the Boards of Appeal Art 13(3)
- Keywords
- Main Request - admissibility (yes);
Main Request - meets all requirements of the EPC (yes) - Catchword
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The case is remitted to the department of first instance with the order to maintain the patent on the basis of the new main request (claims 1 to 12) filed during the oral proceedings and a description to be adapted thereto.